Quality & Compliance

India has held pharma’s interest for decades, but it is a challening market to work in.

Six Sigma has the potential to deliver real cost savings by improving productivity and reducing defects, but making the change is challenging.

Mark Paxton was appointed CEO of Rx-360 in 2015. Here, he discusses the journey so far

Martin Van Trieste tells the emotional story behind the creation of Rx-360

What separates a good model from a bad model in bioprocess development?

Data, data everywhere… But pharma is not making the most out of it.

Collusion, pollution, and a pricing victory for pharma in California… what’s new in business?

Manufacturing specialists must develop cell therapy factories that can meet high demands.

Predicting and measuring protein aggregation is a critical challenge in the formulation of biopharmaceuticals. This article describes an analytical tool that hits the ‘sweet spot’ of protein aggregation measurement

Nominations for the 2017 Power List are now open and will close on February 1, 2017.